Dr. Divya Malini Chalikonda, MD

Dr. Chalikonda practices at Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health.

Dr. Chalikonda's NPI, 1124473921, was assigned on April 28, 2016. Dr. Chalikonda graduated from George Washington University School of Medicine in 2016. Dr. Chalikonda holds Pennsylvania license MD468183.

Dr. Chalikonda's primary practice is Allegheny General Hospital, at 320 East North Avenue, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 359-3131.

Dr. Chalikonda's primary practice is Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Dr. Chalikonda is also affiliated with West Penn Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. Chalikonda to 1 more hospital and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chalikonda practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chalikonda's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chalikonda is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Chalikonda is licensed in Pennsylvania.

CMS data shows 24 Medicare services from Dr. Chalikonda across 1 procedure code in 2022, for 23 Medicare patients. Medicare paid $787 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 23 Medicare patients who saw Dr. Chalikonda in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chalikonda's median patient age at 73, with 51% women.

In 2024, Dr. Chalikonda wrote 15 Medicare Part D claims for 12 patients. 87% of them were for generic drugs. They cover 2 drugs, with $7,158 in total drug cost. In 2022, CMS named 34 claims across 3 drugs.

Dr. Chalikonda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chalikonda as offering telehealth. CMS counts 166 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Chalikonda, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Chalikonda, published from 2015 to 2025. 2021 was the busiest year, with 4. The most frequent topics are COVID-19, Philadelphia and SARS-CoV-2. Dr. Chalikonda has published most often in ACG Case Rep J. Dr. Chalikonda's most frequent co-authors are Shuji Mitsuhashi, MD, Alan Arthur Kubey, MD and Chantel Marie Venkataraman, MD.

CMS Open Payments shows 37 general payments to Dr. Chalikonda from 11 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 84% of the total. Boston Scientific Corporation paid the most, $1,185. It also lists 3 research payments totaling $152 from 2017 to 2018.

Dr. Chalikonda graduated from George Washington University School of Medicine in 2016.